Hungary reduces threshold for reimbursement withdrawals
This article was originally published in Scrip
Executive Summary
The Hungarian parliament has approved amendments to the national pharmaceutical economy act which allows the government to cease reimbursement of medicines whose prices exceed a reference price by 40% or more from January 1st.